原料藥
產(chǎn)品中心
新聞動態(tài)
聯(lián)系我們
行政部 座機 023-61213011
證券部 座機 023-61213003
郵編 401121
地址 重慶市渝北區(qū)黃楊路2號
| 產(chǎn)品名稱 | 英文名 | CAS NO. | 結(jié)構(gòu)式 Structure | Remark & Status | 登記狀態(tài) |
| ?？朴盟帲?/span> | |||||
| 富馬酸喹硫平 | Quetiapine Fumarate | 111974-72-2 |  |
GMP/DMF Korea MFDSCommercial |
A |
| 羅庫溴銨 | Rocuronium bromide | 119302-91-9 |  |
GMP/DMF Indian DCGI Commercial | A |
| 門冬氨酸鳥氨酸 | L-ornithine L-aspartate | 3230-94-2 |  |
GMP/DMF Indian DCGI Commercial | A |
| 酮苯丙氨酸鈣 | α-Ketophenylalanine Calcium | 51828-93-4 |  |
Commercial | A |
| 酮纈氨酸鈣 | Calcium alpha-ketovaline | 51828-94-5 |  |
Commercial | A |
| 酮亮氨酸鈣 | α-Ketoleucine Calcium | 51828-95-6 |  |
Commercial | A |
| 消旋酮異亮氨酸鈣 | D,L-α-Ketoisoleucine Calcium | 66872-75-1 |  |
Commercial | A |
| 消旋羥蛋氨酸鈣 | D,L-α-Hydroxymethionine Calcium | 4857-44-7 |  |
Commercial | A |
| 硫酸羥氯喹 | Hydroxychloroquine sulfate | 747-36-4 |  |
GMP Commercial |
A |
| 艾司奧美拉唑鈉 | Esomeprazole Sodium | 161796-78-7 |  |
GMP Commercial |
A |
| 枸櫞酸莫沙必利 | Mosapride Citrate | 112885-42-4 |  |
DMF Taiwan Commercial | A |
| 奧拉西坦 | Oxiracetam | 62613-82-5 |  |
GMP Korea MFDS Commercial | A |
| 瑞巴派特 | Rebamipide | 90098-04-7 |  |
Korea MFDS Commercial | A |
| 非布司他 | Febuxostat | 144060-53-7 |  |
Commercial | A |
| 鹽酸樂卡地平 | Lercanidipine hydrochloride | 132866-11-6 |  |
Commercial | A |
| 尼麥角林 | Nicergoline | 27848-84-6 |  |
DMF Commercial |
A |
| 酒石酸布托啡諾 | Butorphanol Tartrate | 58786-99-5 |  |
R&D | A |
| 富馬酸替諾福韋二吡呋酯 | Tenofovir disoproxil fumarate | 202138-50-9 |  |
GMP Commercial |
A |
| 抗感染藥物 | |||||
| 替加環(huán)素 | Tigecycline | 220620-09-7 |  |
USDMF #27477 Commercial | A |
| 拉氧頭孢鈉 | Latamoxef Sodium | 64953-12-4 |  |
Commercial | A |
| 頭孢美唑鈉 | Cefmetazole Sodium | 56796-39-5 |  |
GMP/DMF Commercial |
A |
| 頭孢唑肟鈉 | Ceftizoxime sodium | 68401-82-1 |  |
GMP/DMF Indian DCGI Commercial | A |
| 頭孢硫脒 | Cefathiamidine | 33075-00-2 |  |
GMP Commercial | A |
| 鹽酸頭孢替安 | Cefotiam Hydrochloride | 66309-69-1 |  |
GMP Commercial | A |
| 克林霉素磷酸酯 | Clindamycin phosphate | 24729-96-2 |  |
GMP Commercial | A |
| 氨曲南 | Aztreonam | 78110-38-0 |  |
GMP USDMF#27508 Indian DCGI Commercial | A |
| 氨曲南/精氨酸 | Aztreonam And Arginine | ---- |  |
GMP/DMF Commercial |
A |
| 硫酸頭孢匹羅 | Cefpirome sulfate | 98753-19-6 |  |
A | |
| 磺芐西林鈉 | Sulbenicillin Sodium | 28002-18-8 |  |
GMP Commercial |
A |
| 奧硝唑 | Ornidazole | 16773-42-5 |  |
Commercial | A |
| 伏立康唑 | Voriconazole | 137234-62-9 |  |
Commercial | A |
| 頭孢妥侖匹酯 | Cefditoren pivoxil | 117467-28-4 |  |
A | |
| 注冊產(chǎn)品： | |||||
| 鹽酸奈必洛爾 | Nebivolol Hydrochloride | 152520-56-4 |  |
Commercial | I |
| 鹽酸西那卡塞 | Cinacalcet Hydrochloride | 364782-34-3 |  |
Commercial | I |
| 阿維巴坦鈉 | Avibactam Sodium | 1192491-61-4 |  |
Commercial | I |
| 氟氧頭孢鈉 | Flomoxef Sodium | 92823-03-5 |  |
—— | |
| 苯唑西林鈉 | Oxacillin Sodium | 1173-88-2 |  |
A | |
| 吲哚布芬 | Indobufen | 63610-08-2 |  |
A | |
| 吡貝地爾 | Piribedil | 3605/1/4 |  |
I | |
| 雷諾嗪 | Ranolazine | 95635-55-5 |  |
I | |
| 恩格列凈 | Empagliflozin | 864070-44-0 |  |
A | |
| 鹽酸咪達(dá)唑侖 | Midazolam hydrochloride | 59467-96-8 |  |
A | |
| 五水頭孢唑啉鈉（博圣產(chǎn)品名稱：頭孢唑林鈉） | Cefazolin Sodium Pentahydrate（博圣標(biāo)簽?zāi)０嬗⑽模篊efazolin Sodium Hydrate） | 27164-46-1 |  |
—— | |
| ☆☆☆僅供國外市場 | |||||
| 替卡西林鈉/克拉維酸鉀 | Ticarcillin Sodium/Clavulanate Potassium | 30-1&15-1 |  |
DMF Indian DCGI Commercial |
—— |
| 羧芐西林鈉 | Carbenicillin Sodium | 4800-94-6 |  |
Commercial | —— |
| 頭孢磺啶鈉 | Cefsulodine Sodium | 52152-93-9 |  |
Commercial | —— |
| 產(chǎn)品名稱 | 英文名 | CAS NO. | Structure | Remark & Status | 登記狀態(tài) |
| 二氟嗪 | Diazoxide | 364-98-7 |  |
DMF USDMF#32771 Commercial |
DMF USDMF #32771 國內(nèi)可聯(lián)合申報 |
| 酒石酸異丁嗪 | Trimeprazine tartrate | 4330-99-8 |  |
US VMF 6199 Commercial |
USDMF #6199 國內(nèi)可聯(lián)合申報 |
| 磺苯妥英鈉 | Fosphenytoin sodium | 92134-98-0 |  |
DMF USDMF#32816 |
DMF USDMF #32816 |
| 鹽酸帕洛諾司瓊 | Palonosetron Hydrochloride | 135729-62-3 |  |
Commercial | 中、美注冊可提供關(guān)聯(lián) |
| 鹽酸右美托咪定 | Dexmedetomidine hydrochloride | 145108-58-3 |  |
Commercial | Y20190000679 USDMF |
| 硫辛酸 | Thioctic Acid | 1077-28-7 |  |
Commercial | 中、美注冊可提供關(guān)聯(lián) |
| 產(chǎn)品名稱 | 英文名 | CAS NO. | 結(jié)構(gòu)式 Structure | Remark & Status | 登記狀態(tài) |
| 原料藥 | |||||
| 鹽酸吉西他濱 | Gemcitabine Hydrochloride | 122111-03-9 |  |
GMP/ DMF/ Commercial |
A |
| 鹽酸格拉司瓊 | Granisetron Hydrochloride | 107007-99-8 |  |
GMP Commercial |
A |
| 鹽酸昂丹司瓊 | Ondansetron Hydrochloride |
103639-04-9 |  |
GMP Commercial |
A |
| 多索茶堿 | Doxofylline | 69975-86-6 |  |
GMP Commercial |
A |
| 卡維地洛 | Carvedilol | 72956-09-03 |  |
GMP Commercial |
A |
| 舒林酸 | Sulindac | 38194-50-2 |  |
GMP Commercial |
A |
| 枸櫞酸托瑞米芬 | Toremifene Citrate |
89778-27-8 |  |
GMP/ PMDA Commercial |
A |
| 氟馬西尼 | Flumazenil | 78755-81-4 |  |
GMP Commercial |
A |
| 富馬酸福莫特羅 | Formoterol Fumarate |
43229-80-7 |  |
GMP Commercial |
A |
| 鹽酸左西替利嗪 | Levocetirizine Hydrochloride |
130018-87-0 |  |
GMP Commercial |
A |
| 巴氯芬 | Baclofen | 1134-47-0 |  |
GMP Commercial |
A |
| 瑞戈非尼 | Regorafenib | 755037-03-7 |  |
Commercial | A |
| 帕拉米韋 | Peramivir Trihydrate | 1041434-82-5 |  |
Commercial | A |
| 帕米膦酸二鈉 | Pamidronate disodium |
109552-15-2 |  |
GMP Commercial |
A |
| 枸櫞酸托法替布 | Tofacitinib citrate | 540737-29-9 |  |
Commercial | A |
| 硫酸特布他林 | Terbutaline sulfate | 23031-32-5 |  |
R&D | A |
| 在研產(chǎn)品 | |||||
| 嗎啉硝唑 | Marinidazole | 92478-27-8 |  |
R&D | / |
| 重酒石酸去甲腎上腺素 | Noradrenanili Bitartas | 108341-18-0 |  |
R&D | / |
| 噁拉戈利鈉 | Elagolix Sodium | 832720-36-2 |  |
R&D | / |
| 雷芬那辛 | Revefenacin | 864750-70-9 |  |
R&D | / |
| 美阿沙坦鉀 | Azilsartan Medooxomil Potassium | 1417576-00-1 |  |
R&D | / |
| 佩瑪貝特 | Pemafibrate | 848259-27-8 |  |
R&D | / |
| 鹽酸溴己新 | Bromhexine hydrochloride | 611-75-6 |  |
R&D | / |
| 鹽酸甲哌卡因 | （±）-Evodiamine | 1722-62-9 |  |
R&D | / |
| 鹽酸卡利拉嗪 | Cariprazine hydrochloride | 1083076-69-0 |  |
R&D | / |
| 硫酸慶大霉素 | Gentamicin Sulfate | 1405-41-0 |  |
IndianFDA注冊證，證書編號：RC/BD-002757； KoreaFDA注冊證，證書編號：2020-A1-1266 | 登記號：Y20190002059 登記狀態(tài)：A |
